Vaccinex (VCNX) Institutional Ownership $3.71 +0.45 (+13.80%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Vaccinex (NASDAQ:VCNX)CurrentInstitutional OwnershipPercentage50.11%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$496.49KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$3.46M Get VCNX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vaccinex stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data VCNX Institutional Buying and Selling by Quarter Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Vaccinex Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Point72 Asset Management L.P.166,000$564K0.0%+42.4%9.595% 8/15/2024 Armistice Capital LLC94,000$610K0.0%-35.2%5.934% 8/7/2024 AIGH Capital Management LLC108,958$707K0.2%+86.7%6.896% 2/12/2024 AIGH Capital Management LLC817,061$543K0.2%-25.1%6.542% 2/9/2024 Worth Venture Partners LLC654,079$435K0.2%-8.8%5.237% 11/15/2023 Worth Venture Partners LLC717,559$811K0.5%+417.0%16.308% Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 11/15/2023 Armistice Capital LLC680,000$768K0.0%N/A15.455% 11/13/2023 AIGH Capital Management LLC1,090,173$1.23M0.6%-19.4%24.777% 5/15/2023 AIGH Capital Management LLC951,801$380K0.1%-61.2%1.735% 5/1/2023Virtu Financial LLC103,898$42K0.0%N/A0.189% 2/16/2023 AIGH Capital Management LLC2,451,801$1.66M0.5%+17.8%4.915% 5/12/2022 AIGH Capital Management LLC2,081,801$2.63M0.6%N/A4.880% 11/16/2021Telemetry Investments L.L.C.132,500$286K0.4%+10.4%0.430% 11/15/2021 Natixis31,895$69K0.0%N/A0.104% 11/12/2021 Oppenheimer & Co. Inc.31,751$69K0.0%-24.3%0.103% 9/17/2021Virtu Financial LLC38,026$106K0.0%+103.9%0.123% 8/16/2021 Point72 Asset Management L.P.395,522$1.11M0.0%N/A1.390% 8/16/2021Telemetry Investments L.L.C.120,000$336K0.5%+14.3%0.422% 8/16/2021 State Street Corp67,200$188K0.0%N/A0.236% 8/13/2021 Geode Capital Management LLC104,114$291K0.0%+59.4%0.366% 8/13/2021 Vanguard Group Inc.600,624$1.68M0.0%+145.9%2.111% 5/19/2021Virtu Financial LLC18,652$56K0.0%N/A0.066% 5/17/2021 Goldman Sachs Group Inc.20,447$61K0.0%-41.9%0.072% 5/13/2021 Bank of New York Mellon Corp17,954$54K0.0%N/A0.063% 5/12/2021 Geode Capital Management LLC65,331$194K0.0%N/A0.230% 5/12/2021 UBS Group AG28,708$86K0.0%N/A0.101% 5/10/2021 Oppenheimer & Co. Inc.42,951$128K0.0%-24.3%0.151% 5/4/2021 Institute for Wealth Management LLC.20,000$60K0.0%N/A0.070% 2/17/2021 Tacita Capital Inc13,574$28K0.0%N/A0.061% 2/16/2021 Squarepoint Ops LLC40,583$84K0.0%N/A0.181% 2/11/2021 Oppenheimer & Co. Inc.56,751$117K0.0%+141.1%0.254% 12/11/2020Virtu Financial LLC26,249$47K0.0%N/A0.117% (Data available from 1/1/2016 forward) VCNX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of VCNX shares? During the previous two years, the following institutional investors and hedge funds held shares of Vaccinex shares: AIGH Capital Management LLC ($707K), Armistice Capital LLC ($610K), Point72 Asset Management L.P. ($564K), and Worth Venture Partners LLC ($435K), Virtu Financial LLC ($42K).Learn more on VCNX's institutional investors. What percentage of Vaccinex stock is owned by institutional investors? 50.11% of Vaccinex stock is owned by institutional investors. Learn more on VCNX's institutional investor holdings. Which institutional investors have been buying Vaccinex stock? The following institutional investors have purchased Vaccinex stock in the last 24 months: Armistice Capital LLC ($680K), Worth Venture Partners LLC ($578.76K), AIGH Capital Management LLC ($420.59K), Virtu Financial LLC ($103.90K), and Point72 Asset Management L.P. ($49.45K). How much institutional buying is happening at Vaccinex? Institutional investors have bought a total of 1,832,709 shares in the last 24 months. This purchase volume represents approximately $79.20M in transactions. Which Vaccinex major shareholders have been selling company stock? The following institutional investors have sold Vaccinex stock in the last 24 months: AIGH Capital Management LLC ($2.04M), Worth Venture Partners LLC ($63.48K), and Armistice Capital LLC ($51K). How much institutional selling is happening at Vaccinex? Institutional investors have sold a total of 2,149,989 shares in the last 24 months. This volume of shares sold represents approximately $133.46M in transactions. Related Companies CPIX Institutional Ownership TNXP Institutional Ownership ENLV Institutional Ownership TPST Institutional Ownership PIRS Institutional Ownership IBIO Institutional Ownership CYTH Institutional Ownership SPRB Institutional Ownership UBX Institutional Ownership NNVC Institutional Ownership This page (NASDAQ:VCNX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
